Philips Inflationary-Based Non-Invasive Blood Pressure Validation Study

Inclusion Criteria

• Participants must be 3 to 85 years of age.
• Participants, parents or legal guardians of participants must be able to provide informed consent, parental permission, and/or assent form.
• Participants that are between 7 and 17 (inclusive) years of age must provide assent to participate in the study.
• Participants, parents or legal guardians of participants must be able to read or write in English and participants that are between the age of 7-17 must be able to understand English to provide assent.
• Participant must be willing and able to comply with study procedures and duration.
• Participants must have an upper arm circumference in the range of 14-43 centimeters.

Exclusion Criteria

• Participant, parent or legal guardian of participant is unwilling to provide informed consent, parental permission, and/or assent.
• Participants with deformities or abnormalities that may prevent proper application of the device under test.
• Participants with an upper arm circumference less than 14 cm or greater than 43 cm.
• Female participants who are pregnant.
• Female participants who are trying to get pregnant with confirmation of positive urine pregnancy test.
• Participants with known heart arrhythmias.
• Participants with peripheral vascular disease.
• Participants with clotting disorders.

• History of bleeding disorders or personal history of prolonged bleeding from injury.
• History of blood clots.
• Hemophilia.
• Participants that cannot tolerate sitting for up to 1-2 hours.
• Participant with a blood pressure or other demographics that have already been filled.
• Other known health conditions that will prevent safe participation in the study upon disclosure in screening form or verbally.
• Participant is evaluated by the investigator or clinician and found to be medically unsuitable for participation in this study.
• Participants where the Korotkoff sounds (fifth phase (K5)) for determining DBP is not audible.